By enhancing its beneficial anti-tumor effects along with limiting pro-tumor actions, IFN-γ could contribute in establishing promising immunotherapy of cancer, and further reduce risks of tumors acquiring resistance to anti-tumor immunity and/or developing a progressive character. This evidence concerns the gene IFNG and neoplasm.